ASTRAZENECA PHARMACEUTICALS LP

DE

​Biopharmaceutical Company.

Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 18 of its records are shown together here.

Filings
346
Filed By
18
Reported In-House
$73,556,713
Reported By Firms
$10,443,000

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2011 ASTRAZENECA PHARMACEUTICALS LP 2nd Quarter (Apr 1 - June 30)
AMENDED
$680,000
2011 ASTRAZENECA PHARMACEUTICALS LP 4th Quarter (Oct 1 - Dec 31)
AMENDED
$510,000
2011 ASTRAZENECA PHARMACEUTICALS LP 3rd Quarter (July 1 - Sep 30)
AMENDED
$1,420,000
2011 ASTRAZENECA PHARMACEUTICALS LP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$520,000
2011 ASTRAZENECA PHARMACEUTICALS LP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$520,000
2011 FOLEY HOAG LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination (No Activity)
—
2011 FOLEY HOAG LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$45,000
2011 CAPITOL COUNSEL LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination
$30,000
2011 MEHLMAN CONSULTING, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination
$50,000
2011 FOLEY HOAG LLP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$45,000
Page 1 of 3  ·  23 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings